GlassScriptPhysician profile
Gaby Moawad
NPI 1346416484
$1,487,000.45
in general payments reported to CMS, 2019-2025
9 companies · $413K in 2025
The $413K reported for 2025 was more than what 99% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132K · 2020: $87K · 2021: $81K · 2022: $189K · 2023: $304K · 2024: $282K · 2025: $413K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $622K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $210K · Travel and Lodging: $98K · Consulting Fee: $42K · Food and Beverage: $27K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $622,050.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $210,110.00 |
| Travel and Lodging | $97,548.59 |
| Consulting Fee | $41,550.00 |
| Food and Beverage | $27,324.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,484,612.89 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Medtronic, INC. | $1,610.00 | 2024 | |
| Conmed Corporation | $352.00 | 2019-2021 | |
| Ethicon US, LLC | $137.49 | 2021 | |
| Myovant Sciences INC. | $122.80 | 2022 | |
| Steris Corporation | $66.00 | 2020 | |
| Sumitomo Pharma America, INC. | $45.47 | 2023 | Myfembree |
| Avanos Medical | $30.76 | 2019 | |
| Pfizer INC. | $23.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gaby Moawad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.